Carl June, MD, CAR T cell therapy pioneer. Photo: University of Pennsylvania.

A singular vision to eradicate all cancer.

Since the day it was founded, Alliance for Cancer Gene Therapy has been committed to achieving a better understanding of cancer biology and immunology, translating that understanding into game-changing cancer therapies.

Cell therapies can be curative.

The ACGT-Barbara Netter Fund awards grant for T-cell therapy for pediatric brain tumors.

The ACGT-Barbara Netter Fund awards grant for peptide-centric CAR T-cell therapy for neuroblastoma.

A powerful collaboration to advance cell therapy for brain cancer.

ACGT awards second grant to Dr. Crystal Mackall for CAR T-cell therapy research.

$41+ million awarded since 2001.

76 research fellows awarded grants.

42 top medical institutions funded.

How We Use Donations

Research pipeline.

Cure was not a word that was used with confidence 20 or even 10 years ago. With the proven success of CAR-T therapies for blood cancers, we are now working to bring cures to more cancer patients with solid tumors.

Learn More About the Research We Fund

2025 Impact Report

2025 was headlined by the launch of a pair of grants to support high-impact, collaborative research to advance cancer cell and gene therapies for patients with pancreatic cancer. Incentivizing partnerships across different disciplines and institutions, these grants are reshaping how cancer research is funded and conducted.

Read the Latest Impact Report

Meet Emily Whitehead

The ultimate birthday present.

“If Alliance for Cancer Gene Therapy hadn’t funded Carl June’s early research, Emily wouldn’t be here. They saved our family.” – Tom Whitehead

Make a donation to advance our vision for a cure to all cancers.

By focusing on radical new cell and gene therapies that leverage the body’s own biology and immune system, we can control and ultimately eradicate cancer. Your donation today will bring us closer to a cure for cancer tomorrow.

Donate Today